The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.Diabetes is a group of metabolic disorders, chronic condition which is associated with abnormally high level of sugar (glucose) in the blood. South- East Asia currently witnesses 78.3 million people affected with Diabetes which is going to reach 140.2 million by 2040. Western Pacific region witnesses 153.2 million people affected with diabetes and this number is said to reach 214.8 million by 2040.
Browse market data tables and in-depth TOC of the Asia-Pacific Diabetes Care Devices Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-diabetes-care-devices-market-107/
Asia-Pacific has the highest diabetes population with the number increasing in quite an alarming rate. Due to this there is a huge demand in diabetes care devices which is primarily driving the market here. Also, the increasing healthcare costs is driving the market with increased revenues accumulated by the companies in this region. But the market growth is constrained here due to low medical literacy rate which is leading to the fall in sales of devices.
In Asia-Pacific, the diabetes care device market is segmented by type and by country. By type the market has been segmented in to Insulin delivery devices, Diabetes monitoring devices and Diabetes Control Solutions. The products in each of these segments are segregated in the following way: Diabetes Monitoring Devices (Self-blood Monitoring Devices: Blood Glucose Monitoring Devices, Test Strips, Lancets and Hemoglobin A1c Testing Kits; Continuous Glucose Monitoring Devices); Insulin Delivery Devices (Insulin Pens, Insulin Pumps, Jet Injectors and Insulin Syringes) and Diabetes Control Solutions.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-diabetes-care-devices-market-107/request-sample
Geographically, the market in Asia-Pacific region is segmented into China, India, Japan, Korea and Australia. China and India are the leading contributors in this region with large incidence of companies involved in manufacturing diabetes care devices, due to the highest prevalence of diabetes population in their regions. China has the world’s largest population with close to 1.4 billion people, followed by India with around 1.2 billion people in 2014. According to the International Diabetes Federation, China had the largest number of diabetic patients with around 96.2 million diabetic patients followed by India with around 66.8 million diabetic patients in 2014. This represents a majority of approximately 40-45% of the global diabetic population living in India and China, providing significant opportunities for the global diabetes care devices companies to invest in this region.
Roche Diagnostics, Ascensia, Abbott Laboratories, Novo Nordisk, Johnson & Johnson, Tandem and Terumo are the top companies in Asia-Pacific Diabetes Care Devices Market.
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases